We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Superconducting MR Spectrometer

By Biotechdaily staff writers
Posted on 14 Nov 2005
A state-of-the-art superconducting magnet has recently been developed for use in researching biologic macromolecules such as DNA, RNA, enzymes, and other proteins.

The installation of the 800 MHz German-made Bruker (Ettlingen, Germany) magnet was recently completed in a specially built facility at Brandeis University (Waltham, MA, USA). More...
Weighing about seven and a half tons, the magnetic resonance (MR) spectrometer was funded by a U.S.$2 million grant from the U.S. National Institutes of Health (NIH) in a strong competition among research universities. Since 2001, the NIH has funded only three such magnets nationwide, according to Brandeis professor of chemistry Dr. Tom Pochapsky.

Brought in by crane and located at a site protected from large metal objects and radiofrequency interference, the superconducting magnet was actually energized with about the same amount of power consumed by a big stereo, Dr. Pochapsky explained. First, the superconducting electric coils that create the magnetic field were bathed in liquid helium to drop the temperature to 2oKelvin or minus 456o F. Once the coils were super-cooled, electric current was able to pass through them without resistance, creating the magnetic field. Once at field, the magnet uses no power at all, although the large liquid helium tank surrounding the coil needs to be refilled about every six weeks.

Once the magnet has been fully tested, the Brandeis researchers, as well as other Boston-area universities occupied in NIH-funded biomedical research, will use it 24 hours per day. Experiments typically run in weeklong blocks, although some may run for several weeks at a time, according to Dr. Pochapsky.

Magnetic resonance is a physical phenomenon based on the magnetic property of an atom's nucleus. It occurs when the nuclei of certain atoms are immersed in a static magnetic field and then exposed to a second oscillating field, causing them to essentially line up and act in unison, similar to a brigade of marching soldiers, according to Dr. Pochapsky. The electrons, neutrons, and protons within the atom have an inherent characteristic known as "spin” and within the electromagnetic field created by the magnet, the frequency of the spinning motion of the atoms reveals information about the physical, chemical, structural, and electronic properties of the molecule in solution.

MR spectroscopy was first described more than 50 years ago, and is related to MRI imaging used in hospitals as a soft-tissue diagnostic tool. It is also utilized in chemical and biochemical research because it is the most advanced analytic tool available for determining the three-dimensional (3D) structure and motion of biologic molecules in solution. The average hospital-based MRI has an electromagnetic field of approximately 7 Tesla, whereas this superconducting magnet is more than twice as powerful, measuring a magnetic field of 18.8 Tesla, according to Dr. Pochapsky.




Related Links:
Brandeis University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.